Ivanhoe’s Copper Recovery Gains Support From Acid Sales and Solar Power
Kamoa-Kakula’s latest operating update shows how local acid demand and a changing power supply can influence copper margins. Understanding the benefit requires following the project from underground ore through processing, sales and the costs of its continuing recovery.

A copper producer with a second source of income
Ivanhoe Mines’ October 8 operating update reported 76,401 tonnes of copper in saleable products at Kamoa-Kakula in the third quarter, up 18.8% sequentially. Its smelter also realized approximately $900 per tonne for sulphuric acid. That additional product gives the operation another source of income as copper production recovers.
Ivanhoe is a listed mining company with interests in African mineral projects. At Kamoa-Kakula in the Democratic Republic of the Congo, it owns 39.6%, alongside Zijin Mining’s 39.6%, the government’s 20% and Crystal River’s 0.8%. The operating figures discussed here cover the entire project; all dollar amounts are US dollars.
The complex mines ore, concentrates its copper content and processes concentrate into high-purity metal for sale. Its on-site smelter began operating in late 2025 and produces copper that can be cast into anodes for further refining. Customers buying metal and customers buying the smelter’s acid create two revenue streams from the processing chain.
Why the recovery still shapes the business
Kakula suffered seismic activity and partial flooding in May 2025. Restoring production required pumping out water, rehabilitating underground infrastructure and reopening access. That history explains why available ore and mine development remain central to the investment case.
Underground development creates the tunnels and services needed to reach future mining areas. In its July operating report, Ivanhoe described work around Kakula’s lower-grade periphery before extraction could begin in newly developed, higher-grade areas. During this transition, processing more rock can require additional expenditure for each tonne of copper recovered.
The latest quarter produced 68,188 tonnes of copper in concentrate, up 11.5%. Saleable output also included 6,904 tonnes of previously stockpiled copper fines newly designated for sale. These figures track different stages and material movements through the operation and overlap. Concentrate output provides a useful measure of the recovery in freshly processed ore.
Acid connects the smelter to neighbouring mines
Sulphuric acid is a saleable by-product of the smelting process. Nearby mining operations buy it at Kamoa-Kakula’s mine gate, giving the by-product a commercial outlet close to production.
The first-quarter financial results show the scale already achieved: 107,700 tonnes sold to six buyers at an average $467 per tonne, contributing approximately $50 million of revenue. Multiplying the disclosed volume and rounded price gives $50.3 million, consistent with that reported contribution.
Acid therefore enters the copper economics through an established sales channel. Higher prices can improve the return from processing each batch of concentrate, although the benefit depends on volumes sold, customer demand and collections. For valuation, a durable customer base and repeatable sales volumes deserve separate attention from a particularly favourable quarter’s selling price.
Following the cash-cost bridge
Ivanhoe’s second-quarter financial results show how acid credits enter C1 cash costs, a non-IFRS operating-cost measure expressed per payable pound of copper produced. Capital expenditure, financing costs and taxes sit outside this measure.
| US dollars per payable pound | Q1 2026 | Q2 2026 |
|---|---|---|
| Mining | 1.39 | 1.46 |
| Processing | 0.59 | 0.69 |
| Smelter operations | 0.27 | 0.41 |
| Logistics | 0.22 | 0.24 |
| Refining and treatment | 0.12 | 0.08 |
| General and administrative | 0.31 | 0.35 |
| Sulphuric acid credit | (0.32) | (0.39) |
| C1 cash cost | 2.58 | 2.84 |
The Q2 acid credit covered about 95% of smelter operating costs: $0.39 divided by $0.41. Across the whole operation, costs before the credit increased $0.33 per pound; the additional $0.07 credit left a $0.26 increase in C1. Q1 also benefited from partial capitalization of smelter operating costs, affecting the comparison.
This bridge illustrates the investment sensitivity. Acid can support margins while mining and processing expenses move in the opposite direction. A forecast that links copper profitability only to the copper price would miss both influences, especially during an operational recovery.
Power changes another part of the equation
The solar facilities described in July combine solar generation with battery storage to supply continuous power. CrossBoundary Energy and Green World Energie own, fund and operate them, with Kamoa Copper purchasing the electricity. This structure places the generating assets with specialist providers while the mine pays for supply.
By September 23, the facilities had reached their combined 60-megawatt continuous output. Generator diesel consumption in September was 40% below July, as disclosed in the October update. The reduction applies specifically to the generators.
For a recovering underground operation, dependable electricity has operational value as well as a fuel-cost effect. Pumping and processing need continuity; interruptions can delay work and reduce the output over which operating costs are spread. The financial benefit will depend on purchased-power tariffs, diesel savings and operating availability together.
Evidence to watch in the next results
The next financial disclosure should show how acid sales translated into the by-product credit and whether power changes reduced unit costs. Copper shipments, inventory movements and cash collections will help establish how much of the operating improvement reached cash flow.
Management currently expects production toward the lower end of its 290,000–310,000-tonne full-year range. For the mine itself, progress into higher-grade areas and sustained concentrate output remain the measures to follow. Those results will determine how effectively Kamoa-Kakula can use its processing infrastructure while retaining the additional income available from acid sales.
This material is provided for informational and educational purposes only and does not constitute investment advice or a recommendation to buy or sell any security.
Companies Discussed
About AER Insights
Alliance Equity Research publishes timely insights on company-specific developments, industry trends, capital markets activity, and emerging investment themes across global public markets, with a particular focus on undercovered companies, sectors, and developments that often receive limited attention from mainstream financial research. Our analysis focuses on the financial, strategic, and valuation implications behind the headlines, using company disclosures, filings, market data, and sector context to help investors understand what matters, why it matters, and what to watch next.
Get AER Insights by Email
Receive new AER Insights and research updates in your inbox.
Related Insights
Biotechnology & HealthcareAmylyx’s Detailed Avexitide Results Bring a Rare Post-Surgery Condition Closer to Treatment
Amylyx has released detailed Phase 3 results for avexitide, an experimental daily injection for recurrent low blood sugar after gastric bypass. In 78 adults receiving dietary management, the treatment reduced the rate of specified hypoglycemic events over 16 weeks versus placebo. The company plans to seek U.S. approval by year-end and prepare for a possible 2027 launch. The study provides a clearer picture of the potential benefit, while diagnosis, insurance access, the approved patient population and sustained treatment will determine the commercial opportunity.
Biotechnology & HealthcareMilestone Extends Its Cash Runway as CARDAMYST’s Early Sales Lag Launch Costs
Milestone Pharmaceuticals plans to cut operating expenses by approximately 30% as it develops a second potential use for CARDAMYST, its newly launched heart-rhythm nasal spray. Third-quarter product sales reached $963,000, while a separate $2 million licensing milestone accounted for most reported revenue. Management expects its cash to support operations into late 2028, around the time of a Phase 3 readout. Investors must weigh improving prescription activity and insurance coverage against launch spending, sales-based financing obligations and the time needed to establish a sustainable commercial business.
Mining & Critical MineralsAtalaya Adds Two Spanish Copper Projects as Its Growth Pipeline Competes for Capital
Atalaya Mining has acquired the former Tharsis and La Zarza mines in southern Spain for €125 million, adding large copper-bearing resources to a portfolio already led by its operating Riotinto complex and the proposed Touro development. The purchase follows a quarter of record EBITDA, helped by higher copper prices and increased sales. Although Atalaya paid €75 million upfront from cash, another €50 million is due within a year. The value of the expansion will depend on permitting, processing economics and how the new assets fit alongside existing investment priorities.
Mining & Critical MineralsMeridian’s Cabaçal Financing Offers Advance a Mine With Important Terms Unsettled
Meridian Mining has appointed an engineering and construction management contractor for its Cabaçal copper-gold project in Brazil and received indicative financing proposals, including packages totaling $400 million. The project’s feasibility study models a $2.09 billion after-tax net present value, but its initial capital estimate relies on tax credits and excludes financing charges. The financing offers remain subject to negotiation, while the mine installation permit was under review in the October technical report. The crucial issue for investors is how much of the modeled project value Meridian can retain after construction funding, sales arrangements and other obligations are settled.
About Alliance Equity Research
Alliance Equity Research publishes independent and company-sponsored equity research on undercovered, emerging, and high-potential public companies globally. Our analyst-built, model-backed research combines fundamental business analysis, financial forecasting, and valuation.
Email: info@alliancekp.com · Website: https://allianceequityresearch.com
For detailed company research, financial models, or coverage inquiries, contact our research team.
Research commentary for informational purposes. This document does not constitute personalized investment advice or a Buy, Hold, or Sell recommendation. For important disclosures, including information about research sponsorship and potential conflicts of interest, visit allianceequityresearch.com/disclosures.